ARVN Stock Analysis

ARVN -  USA Stock  

USD 79.17  0.52  0.66%

The latest rise in Arvinas short term price appreciation could raise concerns from institutional investors as the firm it trading at a share price of 79.17 on 609,300 in volume. The company executives have successfully maneuvered the firm at convenient times to take advantage of all market conditions in May. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.12. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Arvinas partners.
Please continue to Trending Equities.

Search Stock Analysis 

The Arvinas stock analysis report makes it easy to digest most publicly released information about Arvinas and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. ARVN stock analysis module also helps to analyze the Arvinas price relationship with some important fundamental indicators such as market cap and management efficiency.

ARVN Stock Analysis Notes

About 96.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 3.02. Arvinas had not issued any dividends in recent years. Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was incorporated in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 179 people. For more info on Arvinas please contact John Houston at 203 535 1456 or go to

Arvinas Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Arvinas' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Arvinas or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Arvinas has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 21.8 M. Net Loss for the year was (119.33 M) with profit before overhead, payroll, taxes, and interest of 21.8 M.
Arvinas currently holds about 688.53 M in cash with (89.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.09.
Arvinas has a poor financial position based on the latest SEC disclosures
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from Arvinas Inc falls -3.8930 percent for June 15 -

Arvinas Upcoming and Recent Events

Earnings reports are used by Arvinas to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Arvinas previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of August 2021
Next Earnings Report4th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End7th of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

ARVN Largest EPS Surprises

Earnings surprises can significantly impact Arvinas' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Arvinas SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Arvinas prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Arvinas investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Arvinas specific information freely available to individual and institutional investors to make a timely investment decision.
9th of June 2021
Submission of Matters to a Vote of Security Holders
4th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
1st of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
16th of February 2021
Unclassified Corporate Event
10th of February 2021
Unclassified Corporate Event
8th of February 2021
Unclassified Corporate Event
2nd of February 2021
Unclassified Corporate Event
28th of January 2021
Unclassified Corporate Event

ARVN Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Arvinas is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arvinas backward and forwards among themselves. Arvinas' institutional investor refers to the entity that pools money to purchase Arvinas' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fmr LlcCommon Shares4.2 M280.9 M
Canaan Partners Ix LlcCommon Shares3.6 M237.3 M
Blackrock IncCommon SharesM198.4 M
Vanguard Group IncCommon Shares2.6 M169.4 M
Price T Rowe Associates IncCommon Shares2.4 M157.7 M
New Leaf Venture Partners LlcCommon Shares2.3 M150.9 M
Bellevue Group AgCommon Shares2.1 M136.9 M
Note, although Arvinas' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ARVN Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 4.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arvinas's market, we take the total number of its shares issued and multiply it by Arvinas's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

ARVN Profitablity

Arvinas' profitability indicators refer to fundamental financial ratios that showcase Arvinas' ability to generate income relative to its revenue or operating costs. If, let's say, Arvinas is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Arvinas' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Arvinas' profitability requires more research than a typical breakdown of Arvinas' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.31) (0.34) 
Return on Average Equity(0.38) (0.41) 
Return on Invested Capital(0.72) (0.78) 
Return on Sales(5.47) (5.62) 

Management Efficiency

The entity has return on total asset (ROA) of (15.32) % which means that it has lost $15.32 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (27.47) %, meaning that it created substantial loss on money invested by shareholders. Arvinas management efficiency ratios could be used to measure how well arvinas manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return on Average Assets is estimated to slide to -0.34. The value of Return on Average Equity is estimated to slide to -0.41. Arvinas Total Assets are quite stable at the moment as compared to the past year. The company's current value of Total Assets is estimated at 774 Million. Current Assets is expected to rise to about 758.6 M this year, although the value of Return on Average Assets will most likely fall to (0.34) .
Last ReportedProjected for 2021
Book Value per Share 16.25  17.53 
Enterprise Value over EBIT(28.00) (30.21) 
Enterprise Value over EBITDA(29.15) (31.45) 
Price to Book Value 5.36  5.62 
Tangible Assets Book Value per Share 18.14  17.12 
Enterprise Value3.4 B2.8 B
Tangible Asset Value717.4 M774 M

Technical Drivers

As of the 19th of June, Arvinas shows the Risk Adjusted Performance of 0.0416, mean deviation of 2.48, and Downside Deviation of 3.22. Arvinas technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Arvinas, which can be compared to its rivals. Please confirm Arvinas variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Arvinas is priced correctly, providing market reflects its regular price of 79.17 per share. Given that Arvinas has jensen alpha of 0.1463, we suggest you to validate Arvinas's prevailing market performance to make sure the company can sustain itself at a future point.

Arvinas Price Movement Analysis

The output start index for this execution was thirty-nine with a total number of output elements of twenty-two. Arvinas Triple Exponential Moving Average indicator shows smoothing effect of Arvinas price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average. View also all equity analysis or get more info about triple exponential moving average overlap studies indicator.

Arvinas Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arvinas insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arvinas' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Arvinas insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Arvinas Predictive Daily Indicators

Arvinas intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Arvinas stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Arvinas Forecast Models

Arvinas time-series forecasting models is one of many Arvinas' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arvinas' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Arvinas Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arvinas stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ARVN shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Arvinas. By using and applying ARVN Stock analysis, traders can create a robust methodology for identifying ARVN entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(5.29) (5.42) 
Gross Margin 0.90  0.89 
Profit Margin(5.47) (5.91) 
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was incorporated in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 179 people.

Current ARVN Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ARVN analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ARVN analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
113.89Strong Buy9Odds
Arvinas current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most ARVN analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ARVN stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Arvinas, talking to its executives and customers, or listening to ARVN conference calls.
ARVN Analyst Advice Details

ARVN Stock Analysis Indicators

Arvinas stock analysis indicators help investors evaluate how Arvinas stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Arvinas shares will generate the highest return on investment. By understating and applying Arvinas stock analysis, traders can identify Arvinas position entry and exit signals to maximize returns.
Quick Ratio14.20
Fifty Two Week Low19.68
Revenue Growth-54.70%
Shares Short Prior Month1.9M
Average Daily Volume Last 10 Day540.08k
Average Daily Volume In Three Month400.32k
Shares Percent Shares Out4.69%
Gross Margins100.00%
Short Percent Of Float6.02%
Forward Price Earnings-20.06
Float Shares41.89M
Fifty Two Week High92.77
Enterprise Value To Ebitda-22.49
Fifty Day Average68.65
Two Hundred Day Average68.89
Enterprise Value To Revenue125.50
Please continue to Trending Equities. Note that the Arvinas information on this page should be used as a complementary analysis to other Arvinas' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Arvinas Stock analysis

When running Arvinas price analysis, check to measure Arvinas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arvinas is operating at the current time. Most of Arvinas' value examination focuses on studying past and present price action to predict the probability of Arvinas' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arvinas' price. Additionally, you may evaluate how the addition of Arvinas to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
The market value of Arvinas is measured differently than its book value, which is the value of ARVN that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine Arvinas value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.